Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Screening for protein-protein interactions using Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM).

Margineanu A, Chan JJ, Kelly DJ, Warren SC, Flatters D, Kumar S, Katan M, Dunsby CW, French PM.

Sci Rep. 2016 Jun 24;6:28186. doi: 10.1038/srep28186.

2.

Nore1a drives Ras to flick the P53 senescence switch.

Donninger H, Clark GJ.

Mol Cell Oncol. 2015 Jun 10;3(3):e1055050. doi: 10.1080/23723556.2015.1055050.

3.

Ras signaling through RASSF proteins.

Donninger H, Schmidt ML, Mezzanotte J, Barnoud T, Clark GJ.

Semin Cell Dev Biol. 2016 Oct;58:86-95. doi: 10.1016/j.semcdb.2016.06.007. Review.

PMID:
27288568
4.

New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics.

He M, Zhou Z, Shah AA, Hong Y, Chen Q, Wan Y.

Cell Div. 2016 Mar 31;11:4. doi: 10.1186/s13008-016-0013-6. Review.

5.

NORE1A induction by membrane-bound CD40L (mCD40L) contributes to CD40L-induced cell death and G1 growth arrest in p21-mediated mechanism.

Elmetwali T, Salman A, Palmer DH.

Cell Death Dis. 2016 Mar 17;7:e2146. doi: 10.1038/cddis.2016.52.

6.

Ras Regulates Rb via NORE1A.

Barnoud T, Donninger H, Clark GJ.

J Biol Chem. 2016 Feb 5;291(6):3114-23. doi: 10.1074/jbc.M115.697557.

PMID:
26677227
7.

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.

Deel MD, Li JJ, Crose LE, Linardic CM.

Front Oncol. 2015 Sep 2;5:190. doi: 10.3389/fonc.2015.00190. Review.

8.

High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.

Brommage R, Liu J, Hansen GM, Kirkpatrick LL, Potter DG, Sands AT, Zambrowicz B, Powell DR, Vogel P.

Bone Res. 2014 Oct 28;2:14034. doi: 10.1038/boneres.2014.34.

9.

Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.

Qi Q, Li DY, Luo HR, Guan KL, Ye K.

Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7255-60. doi: 10.1073/pnas.1505917112.

10.

NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.

Donninger H, Calvisi DF, Barnoud T, Clark J, Schmidt ML, Vos MD, Clark GJ.

J Cell Biol. 2015 Mar 16;208(6):777-89. doi: 10.1083/jcb.201408087.

11.

Promoter methylation status of Ras-association domain family members in pheochromocytoma.

Richter AM, Zimmermann T, Haag T, Walesch SK, Dammann RH.

Front Endocrinol (Lausanne). 2015 Feb 19;6:21. doi: 10.3389/fendo.2015.00021.

12.

IIIDB: a database for isoform-isoform interactions and isoform network modules.

Tseng YT, Li W, Chen CH, Zhang S, Chen JJ, Zhou X, Liu CC.

BMC Genomics. 2015;16 Suppl 2:S10. doi: 10.1186/1471-2164-16-S2-S10.

13.

Complex-based analysis of dysregulated cellular processes in cancer.

Srihari S, Madhamshettiwar PB, Song S, Liu C, Simpson PT, Khanna KK, Ragan MA.

BMC Syst Biol. 2014;8 Suppl 4:S1. doi: 10.1186/1752-0509-8-S4-S1.

14.

Structural basis of the heterodimerization of the MST and RASSF SARAH domains in the Hippo signalling pathway.

Hwang E, Cheong HK, Ul Mushtaq A, Kim HY, Yeo KJ, Kim E, Lee WC, Hwang KY, Cheong C, Jeon YH.

Acta Crystallogr D Biol Crystallogr. 2014 Jul;70(Pt 7):1944-53. doi: 10.1107/S139900471400947X.

15.

Rassf5 and Ndr kinases regulate neuronal polarity through Par3 phosphorylation in a novel pathway.

Yang R, Kong E, Jin J, Hergovich A, Püschel AW.

J Cell Sci. 2014 Aug 15;127(Pt 16):3463-76. doi: 10.1242/jcs.146696.

16.

Ras and rheb signaling in survival and cell death.

Ehrkamp A, Herrmann C, Stoll R, Heumann R.

Cancers (Basel). 2013 May 28;5(2):639-61. doi: 10.3390/cancers5020639.

17.

The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.

Gordon M, El-Kalla M, Zhao Y, Fiteih Y, Law J, Volodko N, Anwar-Mohamed A, El-Kadi AO, Liu L, Odenbach J, Thiesen A, Onyskiw C, Ghazaleh HA, Park J, Lee SB, Yu VC, Fernandez-Patron C, Alexander RT, Wine E, Baksh S.

PLoS One. 2013 Oct 16;8(10):e75483. doi: 10.1371/journal.pone.0075483. Erratum in: PLoS One. 2015;10(6):e0131150. PLoS One. 2014;9(1). doi:10.1371/annotation/0ed852a0-eb39-4a28-986f-81f28d870747. Mohamed, Anwar [corrected to Anwar-Mohamed, Anwar]. PLoS One. 2015;10(2):e0118034.

18.

Role of mitofusin 2 (Mfn2) in controlling cellular proliferation.

Chen KH, Dasgupta A, Ding J, Indig FE, Ghosh P, Longo DL.

FASEB J. 2014 Jan;28(1):382-94. doi: 10.1096/fj.13-230037.

19.

Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Zhou Y, Zhang X, Klibanski A.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):16-33. doi: 10.1016/j.mce.2013.09.006. Review.

20.

The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.

Suryaraja R, Anitha M, Anbarasu K, Kumari G, Mahalingam S.

Cell Death Dis. 2013 Mar 28;4:e565. doi: 10.1038/cddis.2013.91.

Items per page

Supplemental Content

Support Center